Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

COVID-associated pancreatitis may disproportionately affect young, overweight men

Key clinical point: COVID-19 may be associated with a distinct subset of pancreatitis that disproportionately affects young, overweight men; of note, clinical course may be less severe than predictive markers suggest.

Major finding: Within 48 hours of admission, median C-reactive protein increased from 31 mg/L to 485 mg/L.

Study details: A case series documenting five patients with SARS-CoV-2–associated pancreatitis.

Disclosures: The investigators reported grants from NIHR, Wellcome Trust, Mylan, and others.

Citation:

Szatmary P et al. Gastroenterology. 2020 Jun 1. doi: 10.1053/j.gastro.2020.05.069.